Unlocking Lobular Steering Group

Meet the Unlocking Lobular Steering Group

The James Lind Alliance Priority Setting Partnership (PSP) helps to make research as meaningful as possible to the people who need it.

It brings together patients, carers and clinicians to agree which treatments should become part of clinical practice and deserve priority attention.

We are confident that our Unlocking Lobular James Lind Alliance Priority Setting Partnership will identify research gaps for Lobular Breast Cancer that will result in real clinical change. We will be agreeing the Top 10 priority changes for primary and secondary/metastatic Lobular breast cancer in the NICE and SIGN treatments guidelines.

Meet the Unlocking Lobular Steering Group

Annalisa Barbieri

Annalisa Barbieri

Lived experience of a Lobular diagnosis

Annalisa Barbieri is a writer and columnist with The Guardian and has been a journalist for 33 years.

Cliona Kirwan

Cliona Kirwan

Oncoplastic Breast Surgeon

I am an Oncoplastic Breast Surgeon at the Nightingale Breast Cancer Centre in Manchester in the UK. I have extensive experience in translational and clinical trials, with a particular interest in complex trials such as de-escalation trials.

At the University of Manchester, I lead the Cancer and Thrombosis Research Group, performing basic, translational and clinical research, investigating the symbiotic relationship between cancer and thrombosis.

Fiona Baber

Fiona Baber

Retired General Practitioner

I was 49 and  full time General practitioner when I was diagnosed with Invasive Lobular Breast Cancer. I knew nothing about it then, nor do the colleagues I have spoken to since. As I have learnt more about the disease over the years I have realised how poorly it is understood by both the clinicians and the public.

I am also a patient advocate on Breast Cancer Now’s Scientific Strategy Committee, which is how I met Claire Turner, Interim CEO of Lobular Breast Cancer UK. I wish to move Lobular research forward with the steering group.

Jennifer Hannon

Jennifer Hannon

Lived experience of a Lobular diagnosis

I was diagnosed with Stage 3C ILC in June 2024 at the age 31 years old and I am still undergoing treatment. Following a missed diagnosis, I’m committed to raising awareness to support earlier detection. I hope to contribute lived experience to research priorities and help to improve outcomes for those affected by Lobular Breast Cancer.

Joanne Edwards

Joanne Edwards

Professor of Translational Cancer Pathology

I am a Professor of Translational Cancer Pathology at the University of Glasgow and Director of the Glasgow Tissue Research Facility.

My research centres on tumour pathology, biomarker discovery and the tumour microenvironment in colorectal and breast cancer, using large, clinically annotated tissue cohorts to translate pathological insights into personalised patient care.

Julia Garlick

Julia Garlick

Lived experience of a Lobular diagnosis

After a long and varied NHS career, I’ve since participated in several PPI initiatives. I’m keen to be involved in the James Lind Alliance priority setting initiative because I’ve had two different breast cancers – ductal and Lobular. The latter becoming Stage 4 (bones) quite quickly, but which has been successfully treated for almost 5 years. I participate in several online breast cancer forums seeking and offering support and a few face-to-face events.

Mandy Boyd

Mandy Boyd

Lived experience of a Lobular diagnosis

I am a retired banker from Northern Ireland. In 2023 I was diagnosed with Lobular Breast Cancer. Since retiring, I am a patient advocate and member of the Department of Health Breast Cancer Strategy Forum in Northern Ireland.

Drawing on my lived experience, I work to ensure that the voices of patients are represented in breast cancer policy, service development, and research. I’m currently establishing a support group for people affected by Lobular Breast Cancer in Northern Ireland, with the aim of improving peer support, awareness, and access to information.

This group will be formed in conjunction with the Elevate Programme in NI.  As a member of the Priority Setting Partnership Steering Group, I am is committed to helping identify and prioritise the research questions that matter most to patients, carers, and healthcare professionals.

Nina Tunariu

Nina Tunariu

Consultant Radiologist

To be added – incl photo

Nusrat Sultan

Nusrat Sultan

Lived experience of a Lobular diagnosis

I have had cancer twice and my resilience defines my journey. At 67, I have dedicated my life to supporting others as a counsellor in Reading and serving my local community.

I am passionate about contributing to cancer research, joining research groups, and fundraising to advance life-saving treatments for others.

 

Sally Kum

Sally Kum

Associate Director of Nursing, healthcare professional engagement and Health Information

I’m the Associate Director of Nursing, healthcare professional engagement and Health Information at Breast Cancer Now.

My clinical background as a nurse has included jobs as a chemotherapy nurse, breast cancer clinical nurse specialist, nurse consultant, and clinical lead for breast services.

I joined Breast Cancer Now in January 2022. I am keen to explore innovative, inclusive and person-centred ways to inform and support those affected by breast cancer.

 

Sara McLennan

Sara McLennan

Psychosocial Oncologist and LBCUK trustee

For the past 20 years I have worked as a Psychosocial Oncologist. I lead research into the impact of cancer and treatment on individual’s lives and methods for involving different stakeholder groups, particularly patients, in the design and delivery of care. This became all the more pertinent in 2022 when I began my own Loular cancer journey and became a patient.

I assumed when given a diagnosis of Lobular that this would be something I could go and read about as easily as a Ductal breast cancer as it was clearly a type to be given a label. Being an Academic and needing lots of information from evidence-based sources that I could trust, I felt totally lost by the lack of this for Lobular Breast Cancer. 

Then I came across Lobular Breast Cancer UK (LBCUK) and I felt a strong sense of trust when talking with Claire and others. I am extremely proud to now be a trustee of LBCUK. 

Sean Ryan

Sean Ryan

Lived experience of a Lobular diagnosis

I am a husband and carer to my wife, who is a Stage IV Lobular Breast Cancer patient. She has been receiving treatment continuously since 2021.

I recently retired from a career in scientific research and leadership, being Emeritus Professor of Astrophysics at the University of Hertfordshire where I served as Head and Dean of the School of Physics, Astronomy and Mathematics from 2005-2015.

I’ve been a member of numerous research advisory committees in the UK, Germany, Australia and the USA.

Simon Lowes

Simon Lowes

Consultant Breast Radiologist

I am a Consultant Breast Radiologist at Gateshead Health NHS Foundation Trust, an  honorary clinical senior lecturer at Newcastle University, and the Royal College of Radiologists’ Roentgen Professor 2026.

My main clinical research interests are in breast cancer diagnosis and treatment, and I recently set up the Northern Centre for Breast Research at Gateshead Health, which supports multidisciplinary breast research. I work closely with scientists at Newcastle University and supervise a number of doctoral students. I’m a strong advocate for supporting research engagement among radiologists, and together with the RCR Academic Committee I’m leading projects to identify and address the challenges that face radiologists engaging in research activities. Recently I set up BRIGHT (Breast Research Imaging Group for Higher Trainees), a national trainee research network, to encourage collaborative multicentre projects for the next generation of breast radiology researchers.

I also have a wide range of other professional roles including Executive Committee Officer/Treasurer of the British Society of Breast Radiology, Member of the RCR Academic Committee, Member of the RCR Professional Practice Board, Member of the NICE breast cancer committee, Advisory Editor (breast) for Clinical Radiology, Associate Editor (breast) for British Journal of Radiology, and member of the NIHR Imaging Group.

Vasileios Angelis

Vasileios Angelis

Consultant Medical Oncologist

I am a Consultant Medical Oncologist at St Bartholomew’s Hospital, London, specialising in the management of early and metastatic breast cancer. I completed my oncology training at The Royal Marsden Hospital and I hold a PhD in Clinical Proteomics in Cancer from the University of Leeds.

I have international clinical experience and am an active contributor to breast cancer clinical trials and medical education. My principal clinical and research interests include Lobular Breast Cancer and early-stage triple-negative breast cancer, with a broader commitment to advancing personalised approaches to breast cancer care.

Delivery team

De Montford University

Kerry Quincy

Kerry Quincy

Chartered Psychologist and Senior Lecturer in Psychology

I’m a Chartered Psychologist and Senior Lecturer in Psychology at De Montfort University. I’m also a founder member of The Men’s Virtual Meet Up (VMU); an online support resource for men diagnosed with breast cancer, which was borne out of my PhD research on this topic.

I’m interested in psycho-oncology and redressing cancer inequalities, and my published works to date largely focus on furthering understandings of lived experiences of underrepresented cancers.

I’ve worked in collaboration with Lobular Breast Cancer UK to develop a series of digital postcards designed to assist patients in conversations with their medical teams, and presented research on Lobular Breast Cancer at an academic conference in 2025.

Iain Williamson

Iain Williamson

Professor and Researcher in the field of psycho-oncology

I’m an experienced researcher in the field of psycho-oncology. I use qualitative research methods to understand and improve the experiences of those living with a range of cancer types including mesothelioma, lung cancer and breast cancer.

James Lind Alliance

Rhiann McLean

Rhiann McLean

James Lind Alliance Facilitator

I’m the James Lind Alliance Adviser supporting the Unlocking Lobular: Lobular Breast Cancer Priority Setting Partnership (PSP).  JLA Advisers act as neutral facilitators, making sure that the PSP process is followed in a fair and transparent way. My role is to bring together the perspectives of people with lived experience and clinicians through chairing of steering groups and wider support.
As a social researcher and public participation specialist with 17 years of experience across health and social care, I have a keen interest in making sure that research reflects the real priorities of communities.

LBCUK PSP leads

Claire Turner

Claire Turner

Interim CEO of LBCUK

The question “How has 7cm of tumour been missed on a mammogram?” was what started me on my journey to setting up LBCUK.

I was diagnosed with Lobular Carcinoma in Situ, a risk factor for breast cancer, in 2014 after first visiting my GP two years before with a strange sensation in my breast. I had a lumpectomy but no invasive breast cancer was found.

It wasn’t until 2017, returning again to the Breast Clinic with a now prominent dent in my breast, that 1cm of a Stage 2 invasive Lobular Breast Cancer tumour was finally found on a mammogram. 

As I began speaking more with international researchers and clinicians, and meeting other patient advocates from around the world, I realised that we needed things to change here in the UK.

I decided to set up Lobular Breast Cancer UK and put a call out across social media. Eight incredible women, all who had had a Lobular Breast Cancer diagnosis, stepped up to help launch the charity.

Helen Coulthard

Helen Coulthard

Reader in Psychology and LBCUK Trustee

I am a Reader in Psychology who specialises in eating behaviour at De Montfort University in Leicester. I live In Birmingham with my family, but originate from North Cumbria.

I was diagnosed with Lobular Carcinoma, grade 3, 6.6cm in size in July 2019. ‘Lobular ‘ was the first word the breast surgeon said to me when I was diagnosed, and then it was subsequently viewed as unimportant for the rest of my treatment.

As a researcher, I turned to research and was stuck by the fact that Lobular has different biological features and grows differently to standard (ductal) cancers, yet the scanning and treatment protocols in the UK are identical. This disparity between knowledge and practice led me to seek out other Lobular patients to see if we could make a difference for future generations.